(Total Views: 330)
Posted On: 10/07/2020 8:50:48 AM
Post# of 132
$JAGX News Article - Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Crofelemer (Mytesi) for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy https://marketwirenews.com/news-releases/jagu...50790.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
